Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

Research output: Contribution to journalArticle

Standard

Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. / Taylor, Rodney; Drummond, KJ; Salkeld, G; Sullivan, SD.

In: British Medical Journal, Vol. 329, 31.12.2004, p. 972-975.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Taylor, Rodney ; Drummond, KJ ; Salkeld, G ; Sullivan, SD. / Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. In: British Medical Journal. 2004 ; Vol. 329. pp. 972-975.

Bibtex

@article{d378c86084e54b748477931809b5414f,
title = "Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle",
author = "Rodney Taylor and KJ Drummond and G Salkeld and SD Sullivan",
year = "2004",
month = dec,
day = "31",
doi = "10.1136/bmj.329.7472.972",
language = "English",
volume = "329",
pages = "972--975",
journal = "British Medical Journal",
issn = "0959-8138",
publisher = "BMJ Publishing Group",

}

RIS

TY - JOUR

T1 - Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

AU - Taylor, Rodney

AU - Drummond, KJ

AU - Salkeld, G

AU - Sullivan, SD

PY - 2004/12/31

Y1 - 2004/12/31

UR - http://www.scopus.com/inward/record.url?scp=6944244438&partnerID=8YFLogxK

U2 - 10.1136/bmj.329.7472.972

DO - 10.1136/bmj.329.7472.972

M3 - Article

C2 - 15499118

VL - 329

SP - 972

EP - 975

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-8138

ER -